11. An economic evaluation of the randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo (the HI‐Light Vitiligo Trial). (1st May 2021) Authors: Sach, T.H.; Thomas, K.S.; Batchelor, J.M.; Perways, A.; Chalmers, J.R.; Haines, R.H.; Meakin, G.D.; Duley, L.; Ravenscroft, J.C.; Rogers, A.; Santer, M.; Tan, W.; White, J.; Whitton, M.E.; Williams, H.C.; Cheung, S.T.; Hamad, H.; Wright, A.; Ingram, J.R.; Levell, N. Journal: British journal of dermatology Issue: Volume 184:Number 5(2021) Page Start: 840 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo: results of the HI‐Light Vitiligo Trial. (1st May 2021) Authors: Thomas, K.S.; Batchelor, J.M.; Akram, P.; Chalmers, J.R.; Haines, R.H.; Meakin, G.D.; Duley, L.; Ravenscroft, J.C.; Rogers, A.; Sach, T.H.; Santer, M.; Tan, W.; White, J.; Whitton, M.E.; Williams, H.C.; Cheung, S.T.; Hamad, H.; Wright, A.; Ingram, J.R.; Levell, N.J. Journal: British journal of dermatology Issue: Volume 184:Number 5(2021) Page Start: 828 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. An economic evaluation of the randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo (the HI‐Light Vitiligo Trial)*. (1st May 2021) Authors: Sach, T.H.; Thomas, K.S.; Batchelor, J.M.; Perways, A.; Chalmers, J.R.; Haines, R.H.; Meakin, G.D.; Duley, L.; Ravenscroft, J.C.; Rogers, A.; Santer, M.; Tan, W.; White, J.; Whitton, M.E.; Williams, H.C.; Cheung, S.T.; Hamad, H.; Wright, A.; Ingram, J.R.; Levell, N. Journal: British journal of dermatology Issue: Volume 184:Number 5(2021) Page Start: 840 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo: results of the HI‐Light Vitiligo Trial*. (1st May 2021) Authors: Thomas, K.S.; Batchelor, J.M.; Akram, P.; Chalmers, J.R.; Haines, R.H.; Meakin, G.D.; Duley, L.; Ravenscroft, J.C.; Rogers, A.; Sach, T.H.; Santer, M.; Tan, W.; White, J.; Whitton, M.E.; Williams, H.C.; Cheung, S.T.; Hamad, H.; Wright, A.; Ingram, J.R.; Levell, N.J. Journal: British journal of dermatology Issue: Volume 184:Number 5(2021) Page Start: 828 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. (1st July 2015) Authors: Chalmers, J.R.; Wojnarowska, F.; Kirtschig, G.; Nunn, A.J.; Bratton, D.J.; Mason, J.; Foster, K.A.; Whitham, D.; Williams, H.C.; Williams, H.; Mason, J.; McDermott, M.; Yong, A.; Chriba, M.; Banks‐Dunnell, K.; Butcher, D.; Cox, N.; Nik, M.; Gilbanks, K.; Davies, K. Journal: British journal of dermatology Issue: Volume 173:Number 1(2015:Jul.) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Dr. J. Graham-Pole and colleagues comment. Issue 8 (August 1976) Authors: Graham-Pole, J.; Ferguson, A.; Gibson, A. A. M.; Stephenson, J. B. P. Journal: Archives of disease in childhood Issue: Volume 51:Issue 8(1976) Page Start: 646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. SAT0400 Influence of Multiple Symptom Domains on Disease Impact in Patients Attending a Multidisciplinary Fibromyalgia Clinic. (23rd January 2014) Authors: Garrood, T.; Medley, S.; Ferguson, A.; Keeling, D.; Duffort, P.; Irving, K. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A718 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Food Antibodies in Serum—A Screening Test for Coeliac Disease. Issue 254 (August 1972) Authors: Carswell, F.; Ferguson, A. Journal: Archives of disease in childhood Issue: Volume 47:Issue 254(1972) Page Start: 594 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Abstract PCCLB-39: THE CHILDREN'S CHELSEA CRITICAL CARE PHYSICAL ASSESSMENT TOOL. (June 2018) Authors: Ferguson, A.; Wright, S.; Long, D.; Stockton, K.; Stocker, C. Journal: Pediatric critical care medicine Issue: Volume 19(2018)Supplement 1 6 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. (26th May 2015) Authors: Chalmers, J.R.; Wojnarowska, F.; Kirtschig, G.; Nunn, A.J.; Bratton, D.J.; Mason, J.; Foster, K.A.; Whitham, D.; Williams, H.C.; the BLISTER study group; Williams, H.; Mason, J.; McDermott, M.; Yong, A.; Chriba, M.; Banks‐Dunnell, K.; Butcher, D.; Cox, N.; Nik, M.; Gilbanks, K. Journal: British journal of dermatology Issue: Volume 173:Number 1(2015:Jul.) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗